Biosimilar Newsletter Archive

41. 10.10.24 -- Upping Flow of Advanced Technologies Into Commercial Manufacturing 10/10/2024
    10/10/24 Biosimilar Development Newsletter
42. 10.03.24 -- The Peril Of Analytical Method Transfer 10/3/2024
    10/03/24 Biosimilar Development Newsletter
43. 10.02.24 -- Dig Into Ideas, Data, And Examples Of Bioprocessing Intensification Strategies 10/2/2024

    10/02/24 Biosimilar Development Newsletter

44. 10.01.24 -- Unlocking Biomanufacturing Success: Partnerships, Immunogenicity, And Tech 10/1/2024

    10/01/24 Biosimilar Development Newsletter

45. 09.26.24 -- 3 Must-Have Skills For Drug Product Formulation & Process Development 9/26/2024
    09/26/24 Biosimilar Development Newsletter
46. 09.19.24 -- Advancing Drug Delivery: Safety, Reliability, And Innovation 9/19/2024

    09/19/24 Biosimilar Development Newsletter

47. 09.19.24 -- The Influence Of Flows In cGMP Architectural Design 9/19/2024
    09/19/24 Biosimilar Development Newsletter
48. 09.18.24 -- Let's Deviate From Deviations - Sterile Drugs. 9/18/2024

    09/18/24 Biosimilar Development Newsletter

49. 09.12.24 -- Get The Most Out Of Your Filtration Processes 9/12/2024

    09/12/24 Biosimilar Development Newsletter

50. 09.12.24 -- FDA Issues Draft Guidance On Use-Related Risk Analysis 9/12/2024
    09/12/24 Biosimilar Development Newsletter